Company
United StatesGlobal Blood Therapeutics, Inc., South San Francisco, CA – FDA Inspections
Inspection records and compliance data for Global Blood Therapeutics, Inc. in South San Francisco, California. 2 FDA inspections on record, 1 Form 483, last inspected March 11, 2022.
Company Profile
This profile covers Global Blood Therapeutics, Inc. based in South San Francisco, California, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 1
- NAI
- 1
- Form 483s
- 1
- Warning letters
- 0
First inspected August 12, 2019. Last inspected March 11, 2022.
Most cited issue areas
- Records of receipt, shipment, disposition1 inspection
- Required label statement1 inspection
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| March 11, 2022 | NAI | Human Drugs · Bioresearch Monitoring | 1166989 |
| August 12, 2019 | VAI | Human Drugs · Bioresearch Monitoring | 1099869 |
FDA documents
Form 483s (1)
People (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Global Blood Therapeutics, Inc.
FEI Number
3014009624
Address
181 Oyster Point Blvd, Room 402 Haight, South San Francisco, California 94080, United States
Country
United States
ID: f8d23240-2082-4157-b284-c0372b4037fb